These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 30576397

  • 21. Myristoylation of the Arenavirus Envelope Glycoprotein Stable Signal Peptide Is Critical for Membrane Fusion but Dispensable for Virion Morphogenesis.
    York J, Nunberg JH.
    J Virol; 2016 Sep 15; 90(18):8341-50. PubMed ID: 27412594
    [Abstract] [Full Text] [Related]

  • 22. Genetic diversity among Lassa virus strains.
    Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST.
    J Virol; 2000 Aug 15; 74(15):6992-7004. PubMed ID: 10888638
    [Abstract] [Full Text] [Related]

  • 23. Machupo Virus Expressing GPC of the Candid#1 Vaccine Strain of Junin Virus Is Highly Attenuated and Immunogenic.
    Koma T, Patterson M, Huang C, Seregin AV, Maharaj PD, Miller M, Smith JN, Walker AG, Hallam S, Paessler S.
    J Virol; 2016 Feb 01; 90(3):1290-7. PubMed ID: 26581982
    [Abstract] [Full Text] [Related]

  • 24. Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease.
    Westover JB, Bailey KW, Wasson SR, Boardman KM, Lustig KH, Amberg SM, Gowen BB.
    Antiviral Res; 2024 Sep 01; 229():105952. PubMed ID: 38945484
    [Abstract] [Full Text] [Related]

  • 25. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
    Kerber R, Reindl S, Romanowski V, Gómez RM, Ogbaini-Emovon E, Günther S, ter Meulen J.
    J Clin Virol; 2015 Mar 01; 64():120-7. PubMed ID: 25549822
    [Abstract] [Full Text] [Related]

  • 26. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM, Rojek JM, Spiropoulou CF, Gundersen AT, Jin W, Shaginian A, York J, Nunberg JH, Boger DL, Oldstone MB, Kunz S.
    J Biol Chem; 2008 Jul 04; 283(27):18734-42. PubMed ID: 18474596
    [Abstract] [Full Text] [Related]

  • 27. Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1.
    Wang MK, Ren T, Liu H, Lim SY, Lee K, Honko A, Zhou H, Dyall J, Hensley L, Gartin AK, Cunningham JM.
    PLoS Pathog; 2018 Sep 04; 14(9):e1007322. PubMed ID: 30265711
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library.
    Lan X, Zhang Y, Jia X, Dong S, Liu Y, Zhang M, Guo J, Cao J, Guo Y, Xiao G, Wang W.
    Antiviral Res; 2022 Jan 04; 197():105230. PubMed ID: 34965446
    [Abstract] [Full Text] [Related]

  • 33. Identification of a broad-spectrum arenavirus entry inhibitor.
    Larson RA, Dai D, Hosack VT, Tan Y, Bolken TC, Hruby DE, Amberg SM.
    J Virol; 2008 Nov 04; 82(21):10768-75. PubMed ID: 18715909
    [Abstract] [Full Text] [Related]

  • 34. Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains.
    Albariño CG, Bird BH, Chakrabarti AK, Dodd KA, White DM, Bergeron E, Shrivastava-Ranjan P, Nichol ST.
    J Virol; 2011 Jan 04; 85(1):112-22. PubMed ID: 20980515
    [Abstract] [Full Text] [Related]

  • 35. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.
    Urata S, Yun N, Pasquato A, Paessler S, Kunz S, de la Torre JC.
    J Virol; 2011 Jan 04; 85(2):795-803. PubMed ID: 21068251
    [Abstract] [Full Text] [Related]

  • 36. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
    Zhu S, Wan W, Zhang Y, Shang W, Pan X, Zhang LK, Xiao G.
    J Virol; 2019 Dec 01; 93(23):. PubMed ID: 31511384
    [Abstract] [Full Text] [Related]

  • 37. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.
    Sci Rep; 2015 Oct 12; 5():14775. PubMed ID: 26456301
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM.
    Arch Virol; 2012 Jan 12; 157(1):121-7. PubMed ID: 21947546
    [Abstract] [Full Text] [Related]

  • 39. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
    Thomas CJ, Casquilho-Gray HE, York J, DeCamp DL, Dai D, Petrilli EB, Boger DL, Slayden RA, Amberg SM, Sprang SR, Nunberg JH.
    J Biol Chem; 2011 Feb 25; 286(8):6192-200. PubMed ID: 21159779
    [Abstract] [Full Text] [Related]

  • 40. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
    Iwasaki M, Ngo N, Cubitt B, Teijaro JR, de la Torre JC.
    J Virol; 2015 Dec 25; 89(23):12166-77. PubMed ID: 26401045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.